As of November 14, 2026, Cellectar Biosciences, Inc. has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on December 11, 2024. No WARN notice under its name is on file in the states covered here (Form 8-K, December 11, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Cellectar Biosciences, Inc.
Free to see. No signup.
People from Cellectar Biosciences, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Cellectar Biosciences, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Cellectar Biosciences, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Cellectar Biosciences have layoffs in 2024? What its filings say
Cellectar Biosciences, Inc. (CIK 1279704) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-12-11
This filing reports Item 2.05, and its section states none of employees affected, share of workforce, locations, charges or timing in a single sentence. The full text is in the filing.
Also on the record for Cellectar Biosciences, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G, by BALYASNY ASSET MANAGEMENT L.P. | 9.99% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by Caligan Partners LP | 5.9% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by SilverArc Capital Management, LLC | 9.99% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G, by StemPoint Capital LP | 9.9% of the class | 5%+ stakes | Source |
| August 13, 2026 | Stake report, Schedule 13G, by Bleichroeder LP | 9.99% of the class | 5%+ stakes | Source |
| August 4, 2026 | Stake report, Schedule 13G, by Empery Asset Management, LP | 9.99% of the class | 5%+ stakes | Source |
| June 5, 2026 | Stake report, Schedule 13G, by JANUS HENDERSON GROUP PLC | 9.99% of the class | 5%+ stakes | Source |
| May 18, 2026 | Leadership change: Andrew Gu appointed, Director, and 1 more | — | Leadership changes | Source |
| May 11, 2026 | Stake report, Schedule 13G, by Stonepine Capital Management, LLC | 9.9% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Bleichroeder LP | 4.61% of the class | 5%+ stakes | Source |
| February 10, 2026 | Stake report, Schedule 13G/A, by Rosalind Advisors, Inc. | 5.5% of the class | 5%+ stakes | Source |
| February 4, 2026 | Stake report, Schedule 13G/A, by Hexstone Capital LLC | 4.9% of the class | 5%+ stakes | Source |
Keep reading
More on Cellectar Biosciences, Inc. and the records around it.
Cellectar Biosciences, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Leadership changes May 2026
- Who owns it
Companies that share a holder
- StemPoint Capital LP also filed stake reports on 4 other companies: Faeth Therapeutics, Inc. (Aug 2026), Surrozen, Inc. (Aug 2026), Xilio Therapeutics, Inc. (Aug 2026)
- Hexstone Capital LLC also filed stake reports on 6 other companies: Global Mofy AI Ltd (Nov 2026), Jet.AI Inc. (Nov 2026), Actuate Therapeutics, Inc. (Oct 2026)
- Caligan Partners LP also filed stake reports on 9 other companies: Avalo Therapeutics, Inc. (Aug 2026), Faeth Therapeutics, Inc. (Aug 2026), Opus Genetics, Inc. (Aug 2026)
Watch Cellectar Biosciences, Inc.
Get an email when Cellectar Biosciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Cellectar Biosciences, Inc.?
Want the whole picture on Cellectar Biosciences, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Cellectar Biosciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cellectar Biosciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 18 records.
Tools for this story
Each opens in a new tab, filled in for Cellectar Biosciences, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Related
- Warner Music Group Corp.: 2 SEC filings, Sep 2024 layoff notice within 90 days (2024-09-19)
- Lexicon Pharmaceuticals, Inc.: 1 SEC filing, Nov 2024 layoff notice within 90 days (2024-11-22)
- Catholic Charities Archdiocese Of Galveston-Houston: 4 WARN notices, 120 employees, Feb 2025 layoff notice within 90 days (2025-02-10)
- Fortune Brands Innovations, Inc.: 1 SEC filing, Jan 2025 layoff notice within 90 days (2025-01-22)
- Repare Therapeutics Inc.: 2 SEC filings, Feb 2025 layoff notice within 90 days (2025-02-25)
- Metropolis Company: 140 jobs, Jan 2025 layoff notice within 90 days (2025-01-22)
Who owns Cellectar Biosciences, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/cellectar-biosciences